Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Vicky Brocklebank
Newcastle Authors
Title
Year
Full text
Andrew Bryant
Jan Lecouturier
Giovany Orozco Leal
Dr Vicky Brocklebank
Dr Sonya Carnell
et al.
Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trial
2025
Laura Bailey
Vikki Bridgett
Dr Vicky Brocklebank
Dr Sally Johnson
Professor David Kavanagh
et al.
Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis using the United Kingdom RaDaR Registry
2025
Giovany Orozco Leal
Professor Luke Vale
Dr Vicky Brocklebank
Andrew Bryant
Dr Thomas Chadwick
et al.
The cost-effectiveness of replacing lifelong therapy of eculizumab with a strategy of disease monitoring for eligible atypical haemolytic uraemic syndrome (aHUS) patients: an economic evaluation of the SETS aHUS trial
2025
Anneliza Andreadi
Dr Vicky Brocklebank
Dr Patrick Walsh
Professor David Steel
Professor Claire Harris
et al.
The Role of Complement Factor I Rare Genetic Variants in Age Related Macular Degeneration in Finland
2025
Anneliza Andreadi
Dr Vicky Brocklebank
Professor Kevin Marchbank
Professor Claire Harris
Professor David Kavanagh
Comprehensive functional characterization of complement factor I rare variant genotypes identified in the SCOPE geographic atrophy cohort
2024
Dr Sally Johnson
Professor David Kavanagh
Professor John Sayer
Dr Edwin Wong
Megan Bates
et al.
Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort
2024
Dr Sally Johnson
Professor David Kavanagh
Professor John Sayer
Dr Edwin Wong
Dr Vicky Brocklebank
Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort
2024
Professor David Kavanagh
Dr Vicky Brocklebank
Dr Sally Johnson
Professor Neil Sheerin
Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum
2024
Dr Edwin Wong
Lee-Ann Naidoo
Sarah Winn
Dr Patrick Walsh
Dr Vicky Brocklebank
et al.
The Annual Report of the National Renal Complement Therapeutics Centre 2022/23
2024
Emily Glover
Dr Kate Smith-Jackson
Dr Vicky Brocklebank
Dr Valerie Wilson
Dr Patrick Walsh
et al.
Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome
2023
Dr Vicky Brocklebank
Dr Patrick Walsh
Dr Kate Smith-Jackson
Dr Thomas Hallam
Professor Kevin Marchbank
et al.
Atypical haemolytic uraemic syndrome in the era of terminal complement inhibition- An observational cohort study
2023